Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shen-yuan-dan for prevention of periprocedural myocardial injury after PCI
ChiCTR-IPR-17011069Phase 4Not yet recruiting
- Sponsor
- Beijing Hospital of Traditional Chinese Medicine
- Start
- Jan 2017
- Countries
- 1
01
Overview
Phase 4, randomised trial in coronary arteriosclerosis and unstable angina comparing Shen-yuan-dan with Placebo (2 arms). Planned start Jan 2017; status: not yet recruiting.
02
Drugs
Shenyuandan
03
Conditions
coronary arteriosclerosisunstable angina
Beyond the preview
Go deeper on ChiCTR-IPR-17011069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011069.